GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of 68.52 billion. The enterprise value is 83.90 billion.
| Market Cap | 68.52B |
| Enterprise Value | 83.90B |
Important Dates
The last earnings date was Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | Nov 14, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.71% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.95B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.10, with an EV/FCF ratio of 10.30.
| EV / Earnings | 24.93 |
| EV / Sales | 2.14 |
| EV / EBITDA | 7.10 |
| EV / EBIT | 9.74 |
| EV / FCF | 10.30 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.19.
| Current Ratio | 0.81 |
| Quick Ratio | 0.52 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 1.70 |
| Debt / FCF | 2.64 |
| Interest Coverage | 10.83 |
Financial Efficiency
Return on equity (ROE) is 21.85% and return on invested capital (ROIC) is 13.67%.
| Return on Equity (ROE) | 21.85% |
| Return on Assets (ROA) | 7.24% |
| Return on Capital (ROIC) | 13.67% |
| Revenue Per Employee | 597,707 |
| Profits Per Employee | 47,933 |
| Employee Count | 70,212 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.18% in the last 52 weeks. The beta is 0.31, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -6.18% |
| 50-Day Moving Average | 19.03 |
| 200-Day Moving Average | 20.35 |
| Relative Strength Index (RSI) | 36.28 |
| Average Volume (20 Days) | 5,199 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of 41.97 billion and earned 3.37 billion in profits. Earnings per share was 0.81.
| Revenue | 41.97B |
| Gross Profit | 30.38B |
| Operating Income | 9.23B |
| Pretax Income | 4.41B |
| Net Income | 3.37B |
| EBITDA | 12.41B |
| EBIT | 9.23B |
| Earnings Per Share (EPS) | 0.81 |
Balance Sheet
The company has 4.31 billion in cash and 21.52 billion in debt, giving a net cash position of -17.22 billion.
| Cash & Cash Equivalents | 4.31B |
| Total Debt | 21.52B |
| Net Cash | -17.22B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 18.03B |
| Book Value Per Share | 4.60 |
| Working Capital | -5.58B |
Cash Flow
In the last 12 months, operating cash flow was 9.95 billion and capital expenditures -1.80 billion, giving a free cash flow of 8.15 billion.
| Operating Cash Flow | 9.95B |
| Capital Expenditures | -1.80B |
| Free Cash Flow | 8.15B |
| FCF Per Share | n/a |
Margins
Gross margin is 72.39%, with operating and profit margins of 22.00% and 8.02%.
| Gross Margin | 72.39% |
| Operating Margin | 22.00% |
| Pretax Margin | 10.52% |
| Profit Margin | 8.02% |
| EBITDA Margin | 29.56% |
| EBIT Margin | 22.00% |
| FCF Margin | 19.42% |
Dividends & Yields
This stock pays an annual dividend of 0.57, which amounts to a dividend yield of 3.40%.
| Dividend Per Share | 0.57 |
| Dividend Yield | 3.40% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 95.58% |
| Buyback Yield | -0.71% |
| Shareholder Yield | 2.69% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.91. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.91 |
| Piotroski F-Score | n/a |